0001493152-24-001076.txt : 20240104 0001493152-24-001076.hdr.sgml : 20240104 20240104160545 ACCESSION NUMBER: 0001493152-24-001076 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231228 FILED AS OF DATE: 20240104 DATE AS OF CHANGE: 20240104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hrkac Frederick CENTRAL INDEX KEY: 0001933130 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38659 FILM NUMBER: 24511817 MAIL ADDRESS: STREET 1: C/O BIOSIG TECHNOLOGIES STREET 2: 55 GREENS FARMS ROAD CITY: WESTPORT STATE: CT ZIP: 06880 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BioSig Technologies, Inc. CENTRAL INDEX KEY: 0001530766 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 264333375 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 55 GREENS FARMS ROAD CITY: WESTPORT STATE: CT ZIP: 06880 BUSINESS PHONE: (203) 409-5444 MAIL ADDRESS: STREET 1: 55 GREENS FARMS ROAD CITY: WESTPORT STATE: CT ZIP: 06880 4 1 ownership.xml X0508 4 2023-12-28 0 0001530766 BioSig Technologies, Inc. BSGM 0001933130 Hrkac Frederick C/O BIOSIG TECHNOLOGIES, INC. 55 GREENS FARMS ROAD WESTPORT CT 06880 1 0 0 0 0 Stock Option (Right to Buy) 0.4742 2023-12-28 4 A 0 600000 0 A 2033-12-27 Common Stock 600000 600000 D Restricted Stock Units 2023-12-28 4 A 0 900000 0 A Common Stock 900000 900000 D One hundred thousand (100,000) of the shares of common stock underlying the stock option shall vest on each monthly anniversary of the date of grant for six consecutive months, provided that the Reporting Person is still providing services to the issuer or a subsidiary on such vesting dates. Each restricted stock unit ("RSU") represents the right to receive, at settlement, one (1) share of common stock. This RSU award was granted on December 28, 2023. Upon the issuer's market valuation of $50,000,000, three hundred thousand (300,000) RSUs shall vest and upon the issuer's market valuation of $100,000,000, six hundred thousand (600,000) RSUs shall vest, subject to the terms and conditions of the BioSig Technologies, Inc. 2023 Long-Term Incentive Plan and the issuer's standard form of Restricted Stock Unit Award Agreement, provided that the Reporting Person is still providing services to the issuer or a subsidiary on such vesting dates. Notwithstanding the foregoing, upon the occurrence of (i) a change in control, or (ii) a termination of service due to death or total and permanent disability, all unvested RSUs shall immediately become vested RSUs. /s/ Kenneth Londoner, attorney-in-fact 2024-01-04